Cargando…

Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy

BACKGROUND: Improvements in laparoscopic partial nephrectomy (LPN) in order to minimize perioperative warm ischemia time (WIT), complications, and consequently patient outcome are desirable. Veriset™ is a ready-to-use hemostatic patch of absorbable oxidized cellulose and hydrogel components that has...

Descripción completa

Detalles Bibliográficos
Autores principales: Erne, Eva, Kruck, Stephan, Todenhoefer, Tilman, Aufderklamm, Stefan, Amend, Bastian, Bedke, Jens, Stenzl, Arnulf, Rausch, Steffen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741715/
https://www.ncbi.nlm.nih.gov/pubmed/33591449
http://dx.doi.org/10.1007/s00464-021-08333-0
_version_ 1784629552800071680
author Erne, Eva
Kruck, Stephan
Todenhoefer, Tilman
Aufderklamm, Stefan
Amend, Bastian
Bedke, Jens
Stenzl, Arnulf
Rausch, Steffen
author_facet Erne, Eva
Kruck, Stephan
Todenhoefer, Tilman
Aufderklamm, Stefan
Amend, Bastian
Bedke, Jens
Stenzl, Arnulf
Rausch, Steffen
author_sort Erne, Eva
collection PubMed
description BACKGROUND: Improvements in laparoscopic partial nephrectomy (LPN) in order to minimize perioperative warm ischemia time (WIT), complications, and consequently patient outcome are desirable. Veriset™ is a ready-to-use hemostatic patch of absorbable oxidized cellulose and hydrogel components that has earlier been implemented in vascular and hepatic surgery. We report our experience using this device in LPN. METHODS: Patients with a solitary malignant renal mass suspicious for renal cancer underwent LPN with either the use of Veriset™ hemostatic patch (n = 40) or conventional suture technique (n = 40). Patient characteristics, operation time and WIT, postoperative course and complications were recorded retrospectively. Tumor complexity was calculated according to the R.E.N.A.L. score. Outcome was determined according to the “trifecta” criteria (negative surgical margin, WIT < 25 min, no complications within 30 days). RESULTS: No significant differences with regard to clinical parameters and median R.E.N.A.L. score (6) were observed between both groups. Operation time (mean 127.1 min vs. 162. 8 min; p = 0.001) and WIT were both lower in the Veriset™ group (14.6 min vs. 20.6 min; p = 0.01). No differences in surgical margins (p = 0.602) and overall complication rates at 30 (p = 0.599) and 90 days (p = 0.611) postoperatively were noticed. The surgical outcome according to “trifecta” was achieved in 65% of patients using Veriset™ and in 57.5% of patients by suture closure, respectively. CONCLUSION: The hemostatic Veriset™ patch can successfully be implemented in LPN. Handling and application appear favorable, thereby reducing operation time and WIT. The present results suggest that the device may represent an alternative to parenchyma suturing in LPN.
format Online
Article
Text
id pubmed-8741715
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-87417152022-01-20 Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy Erne, Eva Kruck, Stephan Todenhoefer, Tilman Aufderklamm, Stefan Amend, Bastian Bedke, Jens Stenzl, Arnulf Rausch, Steffen Surg Endosc Article BACKGROUND: Improvements in laparoscopic partial nephrectomy (LPN) in order to minimize perioperative warm ischemia time (WIT), complications, and consequently patient outcome are desirable. Veriset™ is a ready-to-use hemostatic patch of absorbable oxidized cellulose and hydrogel components that has earlier been implemented in vascular and hepatic surgery. We report our experience using this device in LPN. METHODS: Patients with a solitary malignant renal mass suspicious for renal cancer underwent LPN with either the use of Veriset™ hemostatic patch (n = 40) or conventional suture technique (n = 40). Patient characteristics, operation time and WIT, postoperative course and complications were recorded retrospectively. Tumor complexity was calculated according to the R.E.N.A.L. score. Outcome was determined according to the “trifecta” criteria (negative surgical margin, WIT < 25 min, no complications within 30 days). RESULTS: No significant differences with regard to clinical parameters and median R.E.N.A.L. score (6) were observed between both groups. Operation time (mean 127.1 min vs. 162. 8 min; p = 0.001) and WIT were both lower in the Veriset™ group (14.6 min vs. 20.6 min; p = 0.01). No differences in surgical margins (p = 0.602) and overall complication rates at 30 (p = 0.599) and 90 days (p = 0.611) postoperatively were noticed. The surgical outcome according to “trifecta” was achieved in 65% of patients using Veriset™ and in 57.5% of patients by suture closure, respectively. CONCLUSION: The hemostatic Veriset™ patch can successfully be implemented in LPN. Handling and application appear favorable, thereby reducing operation time and WIT. The present results suggest that the device may represent an alternative to parenchyma suturing in LPN. Springer US 2021-02-16 2022 /pmc/articles/PMC8741715/ /pubmed/33591449 http://dx.doi.org/10.1007/s00464-021-08333-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Erne, Eva
Kruck, Stephan
Todenhoefer, Tilman
Aufderklamm, Stefan
Amend, Bastian
Bedke, Jens
Stenzl, Arnulf
Rausch, Steffen
Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy
title Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy
title_full Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy
title_fullStr Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy
title_full_unstemmed Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy
title_short Versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy
title_sort versatility and clinical effectiveness of a synthetic sealing hemostatic patch as alternative to parenchyma suturing in laparoscopic partial nephrectomy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741715/
https://www.ncbi.nlm.nih.gov/pubmed/33591449
http://dx.doi.org/10.1007/s00464-021-08333-0
work_keys_str_mv AT erneeva versatilityandclinicaleffectivenessofasyntheticsealinghemostaticpatchasalternativetoparenchymasuturinginlaparoscopicpartialnephrectomy
AT kruckstephan versatilityandclinicaleffectivenessofasyntheticsealinghemostaticpatchasalternativetoparenchymasuturinginlaparoscopicpartialnephrectomy
AT todenhoefertilman versatilityandclinicaleffectivenessofasyntheticsealinghemostaticpatchasalternativetoparenchymasuturinginlaparoscopicpartialnephrectomy
AT aufderklammstefan versatilityandclinicaleffectivenessofasyntheticsealinghemostaticpatchasalternativetoparenchymasuturinginlaparoscopicpartialnephrectomy
AT amendbastian versatilityandclinicaleffectivenessofasyntheticsealinghemostaticpatchasalternativetoparenchymasuturinginlaparoscopicpartialnephrectomy
AT bedkejens versatilityandclinicaleffectivenessofasyntheticsealinghemostaticpatchasalternativetoparenchymasuturinginlaparoscopicpartialnephrectomy
AT stenzlarnulf versatilityandclinicaleffectivenessofasyntheticsealinghemostaticpatchasalternativetoparenchymasuturinginlaparoscopicpartialnephrectomy
AT rauschsteffen versatilityandclinicaleffectivenessofasyntheticsealinghemostaticpatchasalternativetoparenchymasuturinginlaparoscopicpartialnephrectomy